3.2. Primary Outcome
During the study period, 89 patients underwent follow-up measurements and were included in the ITT population and 86 patients completed follow-up at week 24. There was no significant difference in mean cfPWV between groups [oral MK-7; 12.2 (11.0, 14.3) m/s to 11.7 (10.2, 14.2) m/s vs. control; 12.1 (11.0, 13.4) m/s to 11.4 (9.8, 13.1) m/s, 